These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 22851815)

  • 1. Optimizing dendritic cell-based immunotherapy: tackling the complexity of different arms of the immune system.
    Van Brussel I; Berneman ZN; Cools N
    Mediators Inflamm; 2012; 2012():690643. PubMed ID: 22851815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cells in cancer immunology and immunotherapy.
    Wculek SK; Cueto FJ; Mujal AM; Melero I; Krummel MF; Sancho D
    Nat Rev Immunol; 2020 Jan; 20(1):7-24. PubMed ID: 31467405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cell-based immunotherapy: a basic review and recent advances.
    Constantino J; Gomes C; Falcão A; Neves BM; Cruz MT
    Immunol Res; 2017 Aug; 65(4):798-810. PubMed ID: 28660480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen delivery by dendritic cells.
    Moll H
    Int J Med Microbiol; 2004 Oct; 294(5):337-44. PubMed ID: 15532992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical application of cancer immunotherapy based on naturally circulating dendritic cells.
    Bol KF; Schreibelt G; Rabold K; Wculek SK; Schwarze JK; Dzionek A; Teijeira A; Kandalaft LE; Romero P; Coukos G; Neyns B; Sancho D; Melero I; de Vries IJM
    J Immunother Cancer; 2019 Apr; 7(1):109. PubMed ID: 30999964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cell therapy in cancer treatment; the state-of-the-art.
    Sadeghzadeh M; Bornehdeli S; Mohahammadrezakhani H; Abolghasemi M; Poursaei E; Asadi M; Zafari V; Aghebati-Maleki L; Shanehbandi D
    Life Sci; 2020 Aug; 254():117580. PubMed ID: 32205087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing dendritic cell-based approaches for cancer immunotherapy.
    Datta J; Terhune JH; Lowenfeld L; Cintolo JA; Xu S; Roses RE; Czerniecki BJ
    Yale J Biol Med; 2014 Dec; 87(4):491-518. PubMed ID: 25506283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of dendritic cells in cancer.
    Lee YS; Radford KJ
    Int Rev Cell Mol Biol; 2019; 348():123-178. PubMed ID: 31810552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized dendritic cell-based tumor immunotherapy.
    Janikashvili N; Larmonier N; Katsanis E
    Immunotherapy; 2010 Jan; 2(1):57-68. PubMed ID: 20161666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active immunization of humans with dendritic cells.
    Dhodapkar MV; Bhardwaj N
    J Clin Immunol; 2000 May; 20(3):167-74. PubMed ID: 10941824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of dendritic cell-based vaccination against infection.
    Fajardo-Moser M; Berzel S; Moll H
    Int J Med Microbiol; 2008 Jan; 298(1-2):11-20. PubMed ID: 17719274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current State of Dendritic Cell-Based Immunotherapy: Opportunities for
    Huber A; Dammeijer F; Aerts JGJV; Vroman H
    Front Immunol; 2018; 9():2804. PubMed ID: 30559743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo pulsed dendritic cell vaccination against cancer.
    Gu YZ; Zhao X; Song XR
    Acta Pharmacol Sin; 2020 Jul; 41(7):959-969. PubMed ID: 32366940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of antigen loading strategies of dendritic cells for tumor immunotherapy.
    Shimizu K; Kuriyama H; Kjaergaard J; Lee W; Tanaka H; Shu S
    J Immunother; 2004; 27(4):265-72. PubMed ID: 15235387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing dendritic cell-based anticancer immunotherapy: maturation state does have clinical impact.
    McIlroy D; Gregoire M
    Cancer Immunol Immunother; 2003 Oct; 52(10):583-91. PubMed ID: 12827310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential approaches for more successful dendritic cell-based immunotherapy.
    Chiang CL; Balint K; Coukos G; Kandalaft LE
    Expert Opin Biol Ther; 2015 Apr; 15(4):569-82. PubMed ID: 25553913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy.
    Schreibelt G; Tel J; Sliepen KH; Benitez-Ribas D; Figdor CG; Adema GJ; de Vries IJ
    Cancer Immunol Immunother; 2010 Oct; 59(10):1573-82. PubMed ID: 20204387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Directing dendritic cell immunotherapy towards successful cancer treatment.
    Sabado RL; Bhardwaj N
    Immunotherapy; 2010 Jan; 2(1):37-56. PubMed ID: 20473346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cell immunotherapy: mapping the way.
    Figdor CG; de Vries IJ; Lesterhuis WJ; Melief CJ
    Nat Med; 2004 May; 10(5):475-80. PubMed ID: 15122249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy exploiting the versatility of dendritic cells.
    Kadowaki N
    Ther Apher Dial; 2003 Jun; 7(3):312-7. PubMed ID: 12924606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.